Biogen Inc. buy Cantor Fitzgerald
Start price
20.12.23
/
50%
€230.20
Target price
20.12.24
€283.73
Performance (%)
-20.89%
Price
11:10
€182.10
Summary
This prediction is currently active. The prediction for Biogen Inc. disappoints with a performance of -20.89%. This prediction currently runs until 20.12.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | -1.914% | -1.914% |
iShares Core DAX® | -1.611% | 3.135% |
iShares Nasdaq 100 | -0.500% | 0.775% |
iShares Nikkei 225® | -1.483% | 4.610% |
iShares S&P 500 | -0.501% | 1.914% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $311.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat